MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ito, K.
Right arrow Articles by Sugiyama, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ito, K.
Right arrow Articles by Sugiyama, Y.

Vol. 59, Issue 5, 1077-1085, May 2001

Charged Amino Acids in the Transmembrane Domains Are Involved in the Determination of the Substrate Specificity of Rat Mrp2

Kousei Ito,1 Hiroshi Suzuki, and Yuichi Sugiyama

Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan

Multidrug resistance-associated protein 2 (MRP2) transports glutathione conjugates, glucuronide conjugates, and sulfated conjugates of bile acids. In the present study, we examined the role of charged amino acids in the transmembrane domains of rat Mrp2, conserved among MRP families, using the isolated membrane vesicles from Sf9 cells infected with the recombinant baculoviruses. By normalizing the transport activity for compounds by that for estradiol 17beta -D-glucuronide (E217beta G), it was indicated that the site-directed mutagenesis from Lys to Met at 325 (K325M) and from Arg to Leu at 586 (R586L) results in a marked reduction in the transport for glutathione conjugates [2,4-dinitrophenyl-S-glutathione (DNP-SG) and leukotriene (LT) C4] without affecting that for 6-hydroxy-5,7-dimethyl-2-methylamino-4-(3-pyridymethyl) benzothiazole glucuronide and taurolithocholate sulfate. In contrast to the reduced affinity for DNP-SG, the affinity for E217beta G was increased severalfold in these mutant Mrp2s, suggesting the amino acids at 325 and 586 play an important role in distinguishing between glutathione and glucuronide conjugates. The comparable affinity for LTD4, LTE4, and LTF4 in these mutant Mrp2s with that in wild-type Mrp2 indicates that recognition of LTC4 metabolites by Mrp2 is different from that of LTC4. The transport activity for glutathione conjugate was retained on R586K, whereas no such complementary cationic amino acid effect was observed in K325R. In addition, R1206M and E1208Q exhibited the loss of transport activity for the tested compounds. The results of the present study demonstrate that the charged amino acids in the transmembrane domain of rat Mrp2 may play an important role in the recognition and/or transport of its substrates.


1 Current address: Faculty of Pharmaceutical Sciences, Chiba University, Yayoi-cho 1-33, Inage-ku, Chiba, 263-8522, Japan.


Copyright © 2001 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
N. Yoshida, T. Takada, Y. Yamamura, I. Adachi, H. Suzuki, and J. Kawakami
Inhibitory Effects of Terpenoids on Multidrug Resistance-Associated Protein 2- and Breast Cancer Resistance Protein-Mediated Transport
Drug Metab. Dispos., July 1, 2008; 36(7): 1206 - 1211.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
Y. Kato, S. Takahara, S. Kato, Y. Kubo, Y. Sai, I. Tamai, H. Yabuuchi, and A. Tsuji
Involvement of Multidrug Resistance-Associated Protein 2 (Abcc2) in Molecular Weight-Dependent Biliary Excretion of {beta}-Lactam Antibiotics
Drug Metab. Dispos., June 1, 2008; 36(6): 1088 - 1096.
[Abstract] [Full Text] [PDF]


Home page
J Biomol ScreenHome page
K. Heredi-Szabo, E. Kis, E. Molnar, A. Gyorfi, and P. Krajcsi
Characterization of 5(6)-Carboxy-2,'7'-Dichlorofluorescein Transport by MRP2 and Utilization of this Substrate as a Fluorescent Surrogate for LTC4
J Biomol Screen, April 1, 2008; 13(4): 295 - 301.
[Abstract] [PDF]


Home page
Drug Metab. Dispos.Home page
M. Ninomiya, K. Ito, R. Hiramatsu, and T. Horie
Functional Analysis of Mouse and Monkey Multidrug Resistance-Associated Protein 2 (Mrp2)
Drug Metab. Dispos., December 1, 2006; 34(12): 2056 - 2063.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
R. G. Deeley, C. Westlake, and S. P. C. Cole
Transmembrane Transport of Endo- and Xenobiotics by Mammalian ATP-Binding Cassette Multidrug Resistance Proteins.
Physiol Rev, July 1, 2006; 86(3): 849 - 899.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
M. Ninomiya, K. Ito, and T. Horie
FUNCTIONAL ANALYSIS OF DOG MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 2 (MRP2) IN COMPARISON WITH RAT MRP2
Drug Metab. Dispos., February 1, 2005; 33(2): 225 - 232.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
P. M. Gerk, W. Li, and M. Vore
ESTRADIOL 3-GLUCURONIDE IS TRANSPORTED BY THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 2 BUT DOES NOT ACTIVATE THE ALLOSTERIC SITE BOUND BY ESTRADIOL 17-GLUCURONIDE
Drug Metab. Dispos., October 1, 2004; 32(10): 1139 - 1145.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
K. Ito, T. Koresawa, K. Nakano, and T. Horie
Mrp2 is involved in benzylpenicillin-induced choleresis
Am J Physiol Gastrointest Liver Physiol, July 1, 2004; 287(1): G42 - G49.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. Haimeur, G. Conseil, R. G. Deeley, and S. P.C. Cole
Mutations of Charged Amino Acids in or near the Transmembrane Helices of the Second Membrane Spanning Domain Differentially Affect the Substrate Specificity and Transport Activity of the Multidrug Resistance Protein MRP1 (ABCC1)
Mol. Pharmacol., June 1, 2004; 65(6): 1375 - 1385.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
T. Li, K. Ito, and T. Horie
Transport of fluorescein methotrexate by multidrug resistance-associated protein 3 in IEC-6 cells
Am J Physiol Gastrointest Liver Physiol, August 8, 2003; 285(3): G602 - G610.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
N. Godinot, P. W. Iversen, L. Tabas, X. Xia, D. C. Williams, A. H. Dantzig, and W. L. Perry III
Cloning and Functional Characterization of the Multidrug Resistance-associated Protein (MRP1/ABCC1) from the Cynomolgus Monkey
Mol. Cancer Ther., March 1, 2003; 2(3): 307 - 316.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
C. J. Oleschuk, R. G. Deeley, and S. P. C. Cole
Substitution of Trp1242 of TM17 alters substrate specificity of human multidrug resistance protein 3
Am J Physiol Gastrointest Liver Physiol, February 1, 2003; 284(2): G280 - G289.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S.-Y. Cai, C. J. Soroka, N. Ballatori, and J. L. Boyer
Molecular characterization of a multidrug resistance-associated protein, Mrp2, from the little skate
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2003; 284(1): R125 - R130.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Haimeur, R. G. Deeley, and S. P. C. Cole
Charged Amino Acids in the Sixth Transmembrane Helix of Multidrug Resistance Protein 1 (MRP1/ABCC1) Are Critical Determinants of Transport Activity
J. Biol. Chem., October 25, 2002; 277(44): 41326 - 41333.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
H. Xiong, H. Suzuki, Y. Sugiyama, P. J. Meier, G. M. Pollack, and K. L. R. Brouwer
Mechanisms of Impaired Biliary Excretion of Acetaminophen Glucuronide after Acute Phenobarbital Treatment or Phenobarbital Pretreatment
Drug Metab. Dispos., September 1, 2002; 30(9): 962 - 969.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
P. M. Gerk and M. Vore
Regulation of Expression of the Multidrug Resistance-Associated Protein 2 (MRP2) and Its Role in Drug Disposition
J. Pharmacol. Exp. Ther., August 1, 2002; 302(2): 407 - 415.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
K. Ito, H. Suzuki, and Y. Sugiyama
Single amino acid substitution of rat MRP2 results in acquired transport activity for taurocholate
Am J Physiol Gastrointest Liver Physiol, October 1, 2001; 281(4): G1034 - G1043.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D.-W. Zhang, S. P. C. Cole, and R. G. Deeley
Identification of a Nonconserved Amino Acid Residue in Multidrug Resistance Protein 1 Important for Determining Substrate Specificity. EVIDENCE FOR FUNCTIONAL INTERACTION BETWEEN TRANSMEMBRANE HELICES 14 AND 17
J. Biol. Chem., September 7, 2001; 276(37): 34966 - 34974.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K.-i. Ito, C. J. Oleschuk, C. Westlake, M. Z. Vasa, R. G. Deeley, and S. P. C. Cole
Mutation of Trp1254 in the Multispecific Organic Anion Transporter, Multidrug Resistance Protein 2 (MRP2) (ABCC2), Alters Substrate Specificity and Results in Loss of Methotrexate Transport Activity
J. Biol. Chem., October 5, 2001; 276(41): 38108 - 38114.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics